Cardiac Rehabilitation Market is expected to reach US$ 2,865.42 Mn by 2028

Angioplasty Segment to Hold Largest Market Share by Application During 2021–2028

According to our new research study on “Cardiac Rehabilitation Market Forecast to 2027 – COVID-19 Impact and Global Analysis – by Product, Application, and End-User,” the market is expected to reach US$ 2,865.42 million by 2028 from US$ 1,780.98 million in 2020; it is estimated to grow at a CAGR of 6.2% from 2021 to 2028. The report highlights trends prevailing in the market and factors driving its growth. The growth of the cardiac rehabilitation market is mainly attributed to the factors such as rising incidence of cardiovascular diseases and growing adoption of tele-cardiac rehabilitation. However, the high cost of cardiac rehabilitation equipment hinders the market growth.

Based on application, the cardiac rehabilitation market is segmented into angioplasty, coronary artery disease, cardiomyopathy, cholesterol management, diabetes, and lung transplant. The angioplasty segment held the largest market share in 2020 and is expected to retain its dominance during the forecast period. The increasing number of angioplasties is contributing to the market growth for this segment. For instance, as per the AHA 2019 Heart Disease and Stroke Statistics, around 480,000 patients underwent percutaneous coronary intervention (PCI) in the US in 2014.

Halma plc; OMRON Corporation; AVECINNA; Koninklijke Philips N.V.; General Electric Company; Core Health & Fitness, LLC; Peloton Interactive, Inc.; Resideo Technologies, Inc; ergoline GmbH; and HealthCare International are among the leading companies operating in the cardiac rehabilitation market.

Cardiac Rehabilitation Market, by Region, 2020 (%)

---

Cardiac Rehabilitation Market to Grow at a CAGR of 6.2% to reach US$ 2,865.42 Million from 2020 to 2028

Download Free Sample

---

Cardiac Rehabilitation Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product (Heart Rate Monitor, Stabilization Balls, Treadmill, Rower, Elliptical Trainer, Blood Pressure Monitor, Stationary Bicycle, and Others), Application (Angioplasty, Coronary Artery Disease, Cardiomyopathy, Cholesterol Management, Diabetes, and Lung Transplant), and End-User (Hospitals & Clinics, Specialty Hospitals, Home Healthcare, Cardiac Rehabilitation Centers, and Others)

The report segments the cardiac rehabilitation market as follows:

By Product

• Treadmill
• Elliptical Trainer
• Stationary Bicycle
• Blood Pressure Monitor
• Rower
• Heart Rate Monitor
• Stabilization Balls
• Others

By Application

• Angioplasty
• Coronary Artery Disease
• Cardiomyopathy
• Cholesterol Management
• Diabetes
• Lung Transplant

By End User

• Cardiac Rehabilitation Centers
• Home Healthcare
• Specialty Hospitals
• Hospitals
• Others

By Geography

• North America
  • • US
    • Canada
    • Mexico
• Europe
  • • France
    • Germany
    • UK
    • Spain
    • Italy
    • Rest of Europe
• Asia Pacific (APAC)
  • • China
    • India
    • Japan
    • Australia
    • South Korea
    • Rest of Asia Pacific
• Middle East and Africa (MEA)
  • • Saudi Arabia
    • UAE
    • South Africa
    • Rest of Middle East and Africa
• South and Central America (SCAM)
  • • Brazil
    • Argentina
    • Rest of South and Central America